Serum antiguanosine antibodies as a marker for SLE disease activity and pathogen potential

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 9-16

  Colburn, Keith K ^a,b   Green, Lora M ^a,b,c  

^a Department of Rheumatology ^*  (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Antiguanosine; Antinuclear antibodies; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA ANTIBODY; DOUBLE STRANDED DNA; EPITOPE; GUANOSINE ANTIBODY; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN G ANTIBODY; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN BINDING; AUTOIMMUNITY; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; LYMPHOCYTE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CELL MEMBRANE PERMEABILITY; GUANOSINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITOCHONDRIA;

EID: 33746532302     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.015     Document Type: Review

References (59)

1. Alarcon-Segovia D., Fishbein E., and Estrada-Parra S. The heterogeneity of anti-DNA antibodies in systemic lupus erythematosus and other diseases. J Rheumatol 2 (1975) 172-177
2. Morimoto C., Steinberg A.D., Schlossman S.F., and Borel Y. In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus. J Clin Invest 71 (1983) 1402-1409
3. Weisbart R.H., Garrett R.A., Liebling M.R., Barnett E.V., Paulus H.E., and Katz D.H. Specificity of anti-nucleoside antibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 27 (1983) 403-411
4. Jacob L., Kerjaschki D., Viard J.P., et al. Potential pathogenic role of cell-surface polypeptides, cross-reactive with DNA, in systemic lupus erythematosus. Nephrologie 10 3 (1989) 139-140
5. Roitt I.M., Hutchings P.R., Dawe K.I., Sumar N., Bodman K.B., and Cooke A. The forces driving autoimmune disease. J Autoimmun (1992) 11-26 Suppl A
6. George J., Gilburd B., and Shoenfeld Y. The emerging concept of pathogenic natural autoantibodies. Hum Antibodies 8 2 (1997) 70-75
7. Jang Y.J., and Stollar B.D. Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol Life Sci 60 2 (2003) 309-320
8. O'Brien T.F., Mayer K.H., Hopkins J.D., and Chao L. New concepts in medical bacteriology. J Med 14 4 (1983) 271-280
9. Sela U., Hershkoviz R., Cahalon L., Lider O., and Mozes E. Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretion. J Immunol 174 1 (2005) 302-309
10. Qureshi F., Yang Y., Jaques S.M., et al. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. Am J Reprod Immunol 44 3 (2000) 136-142
11. Mageed R.A., and Zack D.J. Cross-reactivity and pathogenicity of anti-DNA autoantibodies in systemic lupus erythematosus. Lupus 11 12 (2002) 783-786
12. Ohnishi K., Ebling F.M., Mitchell B., Singh R.R., Hahn B.N., and Tsao B.P. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol 6 6 (1994) 817-830
13. Bernstein K.A., Kahl L.E., Balow J.E., and Lefkowith J.B. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity. Clin Exp Immunol 98 (1994) 60-65
14. Foster M.H., Cizman B., and Madaio M.P. Biology of disease. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest 69 (1993) 494-507
15. Krishnan C., and Kaplan M.H. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of γ-globulin from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest 46 (1967) 569-579
16. Weisbart R.H., Noritake D.T., Wong A.L., Chan G., Kacena A., and Colburn K.K. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. J Immunol 144 7 (1990) 2653-2658
17. Schur P.H., and Sandson J. Immunologic factors and clinical activity in lupus erythematosus. New Engl J Med 278 (1968) 533-538
18. Zack D.J., Stempniak M., Wong, Taylor C., and Weisbart R.H. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol 157 (1996) 1082-1088
19. Weisbart R.H., Stempniak M., Harris S., Zack D.J., and Ferreri K. An autoantibody is modified for use as a delivery system to target the cell nucleus: therapeutic implications. J Autoimmun 11 (1998) 539-546
20. Tan E.M., Schur P.H., Carr R.I., and Kunkel H.G. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45 (1966) 1732-1742
21. Pincus T., Schur P.H., Rose J.A., Decker J.L., and Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med 281 (1969) 701-705
22. Stollar D. The specificity and applications of antibodies to helical nucleic acids. Crit Rev Biochem 3 (1975) 45-69
23. Hughs G.R.V., Cohen S.A., and Christian C.L. Anti-DNA activity in systemic lupus erythematosus. Ann Rheum Dis 30 (1971) 259-264
24. Linnik M.D., Hu J.Z., Heilbrunn K.R., Strand V., Hurley F.L., Joh T., and and the LJP 394 Investigator Consortium. Relationship between anti-double stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 52 4 (2005) 1129-1137
25. Erlanger B.F., and Beiser S.M. Antibodies specific for ribonucleosides and ribonucleotides and their reaction with DNA. Proc Natl Acad Sci 52 (1964) 68-74
26. Erlanger B.F., Senitzer D., Miller O.J., and Beiser S.M. Nucleic acid-reactive antibodies specific for nucleosides and nucleotides. Karolinska symposia of research methods in reproductive endocrinology, 5th symposium gene transcription in reproductive tissue, May 29-31 (1972) 206-221
27. Borel Y., Lewis R.M., Andre-Schwartz J., and Stollar B.D. Treatment of lupus nephritis in adult (NZB+NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens. J Clin Invest 61 (1978) 276-286
28. Borel Y., Lewis R.M., and Stollar B.D. Prevention of murine lupus nephritis by carrier dependent induction of immunologic tolerance to denatured DNA. Science 182 (1973) 76-78
29. Humayun M.Z., and Jacob T.M. Specificity of anti-nucleoside antibodies. Biochem J 141 (1974) 313-315
30. Eshhar Z., Benacerraf B., and Katz D.H. Induction of tolerance to nucleic acid determinants by administration of a complex of nucleoside d-glutamic acid and d-lysine (d-LG). J Immunol 114 2 (1975) 872-876
31. Morimoto C., Masuho Y., Borel Y., Steinberg A.D., and Schlossman S.F. Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate. J Immunol 131 4 (1983) 1762-1764
32. Stollar B.D., and Borel Y. Nucleoside specificity in the carrier IgG-dependent induction of tolerance. J Immunol 117 4 (1976) 1308-1313
33. Stollar B.D. The experimental induction of antibodies to nucleic acids. Methods Enzymol 70 (1980) 70-85
34. Borel Y., and Young M.C. Nucleic acid-specific suppressor T cells. Proc Natl Acad Sci U S A 79 (1980) 1593
35. Naikl M., Imai Y., and Osawa T. Establishment of a nucleoside-specific suppressor T cell line from SLE prone (NZB/NZW)F1 mice. J Immunol 135 2 (1985) 1080-1085
36. Borel Y., Borel H., Schneeberger E., and Lewis R.M. Influence of intravenous administration of nucleoside-coupled spleen cells on murine lupus nephritis in female (NZB×NZW)F1 mice. Clin Immunol Immunolopathol 30 (1984) 451-460
37. Weisbart R.H., Garrett R.A., Liebling M.R., Barnett E.V., Paulus H.E., and Katz D.H. Specificity of anti-nucleoside antibodies in systemic lupus erythematosus. Clin Immunol Immunolopathol 27 (1983) 403-411
38. Munns T.W., Liszewiski M.K., and Hahn B.H. Antibody-nucleic acid complexes. Antigenic domains within nucleosides as defined by solid-phase immunoassay. Biochemistry 23 (1984) 2958-2964
39. Munns T.W., and Liszewiski M.K. Antibodies specific for modified nucleosides: an immunochemical approach for the isolation and characterization of nucleic acids. Prog Nucl Acid Res Mol Biol 24 (1980) 109-165
40. Weisbart R.H., Chan G., Kacena A., and Saxton R.E. Characterization of mouse and human monoclonal antibodies cross-reactive with SLE serum antibodies to guanosine. J Immunol 132 6 (1984) 2909-2912
41. Weisbart R.H., and Colburn K.K. Effect of corticosteroids on serum autoantibodies in man. J Immunol Pharmacol 8 (1984) 97-101
42. Weisbart R.H., Yee W.S., Colburn K.K., Whang S.H., Heng M.K., and Boucek R.J. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus. Ann Intern Med 104 (1986) 310-313
43. Totoritis M.C., Tan E.M., McNally M.D., and Rubin R.L. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. New Engl J Med 318 (1988) 1431-1436
44. Colburn K.K., Gusewitch G.A., Pooprasert S., and Weisbart R.H. Apheresis enhances the selective removal of anti-DNA antibodies in SLE. Clin Rheumatol 9 (1990) 475-482
45. Colburn K.K., Boucek R.J., Gusewitch G., and Wong A.L. B-adrenergic receptor stimulation increases anti-DNA antibody production in MRL/lpr mice. J Rheumatol 17 (1990) 138-141
46. Weisbart R.H., Noritake D.T., Wong A.L., Chan G., Kacena A., and Colburn K.K. A conserved anti-DNA antibody ideotype associated with nephritis in murine and human systemic lupus erythematosus. J Immunol 144 (1990) 2653-2658
47. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
48. Colburn K.K., Green L.M., and Wong A.L. Circulating antibodies to guanosine in SLE: correlation with nephritis and polyserositis by acute and longitudinal analysis. Lupus 10 (2001) 411-417
49. Bombardier C., Gladman D.D., Urowitz M.B., Carron D., Chang C.H., and and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35 (1992) 630-640
50. Colburn K.K., Wong A.L., Weisbart R.H., and Green L.M. Antiguanosine antibodies in murine and human lupus have the internal image of G-binding proteins. J Rheumatol 30 5 (2002) 993-997
51. Pai E.F., Kasbach W., Krezel U., Holmes K.C., John J., and Wittinghofer A. Structure of the guanine nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate confirmation. Nature 341 (1989) 209-214
52. Katsaros E.P., Colburn K.K., Casiano C., Lilly M., Weisbart R.H., and Green L.M. Lupus associated antiguanosine antibodies interfered with cAMP and pKA levels. J Invest Med 49 (2001) 73A (Supp)
53. Ternynck T., Avramaes A., Ragimbeau J., Buttin G., and Avrameas S. Immunochemical, structural, and translocating properties of anti-DNA antibodies from (NZB×NZW)F1 mice. J Autoimmun 11 (1998) 511-521
54. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun 11 (1998) 557-561
55. Lemoine N.R., Mayall E.S., Jones T., et al. Characterization of human thyroid epithelial cells immortalized in vitro by simian virus 40 DNA transfection. Br J Cancer 60 6 (1989) 897-903
56. Green L.M., Reade J.L., and Ware C.F. Rapid calorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70 (1984) 257-268
57. Katsaros E.P., Casiano C., Colburn K.K., et al. Lupus associated anti-guanosine antibodies: potential pathogenic effects. Arthritis Rheum 45:9 (2001) S281 (Supp)
58. Taylor M.B., Colburn K.K., and Green L.M. Lupus associated antiguanosine antibodies fine specificity and nucleoside binding properties. J Invest Med 51 (2003) S143-S144 (Supp)
59. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34 2 (2004) 501-537